Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee
The PBAC Guidelines explain in detail how to prepare a submission to list a new medicine or medicinal product on the Pharmaceutical Benefits Schedule (ie for public funding). The guidelines provide detailed instructions on what information is required by the Pharmaceutical Benefits Advisory Committee (PBAC) and the Economic Sub-Committee (ESC) to support a proposed new medicine, and the most appropriate form of clinical evidence and economic evaluation for specific submissions.
Submission structure for a major submission
Phone: 02 6289 7099
Pharmaceutical Evaluation Branch,
Department of Health,
GPO Box 9848,
CANBERRA ACT 2601